Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Current Deferred Revenue (2016 - 2017)

Historic Current Deferred Revenue for Nephros (NEPH) over the last 8 years, with Q4 2017 value amounting to $70000.0.

  • Nephros' Current Deferred Revenue fell 6916.3% to $70000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $70000.0, marking a year-over-year decrease of 6916.3%. This contributed to the annual value of $70000.0 for FY2017, which is 6916.3% down from last year.
  • Nephros' Current Deferred Revenue amounted to $70000.0 in Q4 2017, which was down 6916.3% from $70000.0 recorded in Q3 2017.
  • In the past 5 years, Nephros' Current Deferred Revenue registered a high of $1.1 million during Q1 2014, and its lowest value of $70000.0 during Q1 2015.
  • Moreover, its 5-year median value for Current Deferred Revenue was $374000.0 (2016), whereas its average is $388450.0.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first plummeted by 9343.34% in 2015, then surged by 47142.86% in 2016.
  • Nephros' Current Deferred Revenue (Quarter) stood at $703000.0 in 2013, then tumbled by 30.73% to $487000.0 in 2014, then decreased by 14.37% to $417000.0 in 2015, then plummeted by 45.56% to $227000.0 in 2016, then tumbled by 69.16% to $70000.0 in 2017.
  • Its Current Deferred Revenue stands at $70000.0 for Q4 2017, versus $70000.0 for Q3 2017 and $70000.0 for Q2 2017.